Trial intelligence / Profile preview

Testosterone Replacement in NASH

NCT01919294Phase 2Completed

Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
Start
Jul 2013
Primary completion
Jan 2017
Modality
Hormone, Biologic
Countries
1
01

Overview

A Phase 2 trial of testosterone undecanoate in Nonalcoholic steatohepatitis (NASH), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Started Jul 2013; status: completed.

02

Drugs

testosterone undecanoate
03

Conditions

Nonalcoholic steatohepatitis (NASH)

Beyond the preview

Go deeper on NCT01919294.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01919294.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call